Literature DB >> 8073947

Generating the antibody repertoire in rabbit.

K L Knight1, M A Crane.   

Abstract

We describe a model for B cell development and generation of the antibody repertoire in rabbits. In this model, B cells develop early in ontogeny, migrate to GALT, and undergo the first round of diversification by a somatic gene conversion-like process and by somatic mutation. We designate the repertoire developed by this mechanism as the primary antibody repertoire and it is this repertoire that makes the rabbit immunocompetent. We invoke GALT as the site for development of the primary repertoire because (1) surgical removal of GALT from neonatal rabbits results in highly immunocompromised animals, (2) in germfree rabbits essentially no lymphoid development occurs in GALT and the rabbits are immunoincompetent, and (3) the follicular development of rabbit GALT is highly similar to that of the chicken bursa, the site in which the primary antibody repertoire develops by somatic gene conversion in chicken. We suggest that once the primary antibody repertoire is formed, it is maintained by self-renewing CD5+ B cells and is expanded to a secondary antibody repertoire after the B cells encounter antigen.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8073947     DOI: 10.1016/s0065-2776(08)60452-6

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  14 in total

1.  Antibody repertoire development in fetal and newborn piglets, III. Colonization of the gastrointestinal tract selectively diversifies the preimmune repertoire in mucosal lymphoid tissues.

Authors:  J E Butler; J Sun; P Weber; P Navarro; D Francis
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

Review 2.  Evolution and the molecular basis of somatic hypermutation of antigen receptor genes.

Authors:  M Diaz; M F Flajnik; N Klinman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-01-29       Impact factor: 6.237

3.  Rabbit monoclonal antibody: potential application in cancer therapy.

Authors:  Lifeng Feng; Xian Wang; Hongchuan Jin
Journal:  Am J Transl Res       Date:  2011-04-23       Impact factor: 4.060

4.  The contribution of Bruce Glick to the definition of the role played by the bursa of Fabricius in the development of the B cell lineage.

Authors:  D Ribatti; E Crivellato; A Vacca
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

5.  Microbial induction of B and T cell areas in rabbit appendix.

Authors:  Nicholas B Hanson; Dennis K Lanning
Journal:  Dev Comp Immunol       Date:  2008-02-25       Impact factor: 3.636

6.  Ectopic gene targeting exhibits a bimodal distribution of integration in murine cells, indicating that both intra- and interchromosomal sites are accessible to the targeting vector.

Authors:  G Dellaire; N Lemieux; A Belmaaza; P Chartrand
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

7.  Requirement for BAFF and APRIL during B cell development in GALT.

Authors:  Venkata A Yeramilli; Katherine L Knight
Journal:  J Immunol       Date:  2010-04-16       Impact factor: 5.422

Review 8.  Molecular bases of genetic diversity and evolution of the immunoglobulin heavy chain variable region (IGHV) gene locus in leporids.

Authors:  Ana Pinheiro; Dennis Lanning; Paulo C Alves; Rose G Mage; Katherine L Knight; Wessel van der Loo; Pedro J Esteves
Journal:  Immunogenetics       Date:  2011-05-20       Impact factor: 2.846

9.  A preliminary analysis of the immunoglobulin genes in the African elephant (Loxodonta africana).

Authors:  Yongchen Guo; Yonghua Bao; Hui Wang; Xiaoxiang Hu; Zhihui Zhao; Ning Li; Yaofeng Zhao
Journal:  PLoS One       Date:  2011-02-25       Impact factor: 3.240

10.  Position of O-Acetylation within the Capsular Repeat Unit Impacts the Biological Properties of Pneumococcal Serotypes 33A and 33F.

Authors:  Brady L Spencer; Jamil S Saad; Anukul T Shenoy; Carlos J Orihuela; Moon H Nahm
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.